Overview

Autoimmunity describes a state in which the body's defense system reacts against its own cells and tissues rather than only against external threats. A healthy immune system normally distinguishes self from non‑self and eliminates pathogens such as viruses, bacteria and other pathogens. When tolerance to self is lost, the immune response can recognize native proteins or cells as targets and mount attacks that produce inflammation and tissue damage. That phenomenon is a medical concern and is commonly referred to as an autoimmune condition.

Mechanisms and characteristics

Autoimmunity arises from a breakdown of immune tolerance. Key players include autoantibodies produced by B cells and autoreactive T cells that infiltrate tissues. Contributing factors are genetic susceptibility, environmental triggers, infections that imitate self‑proteins (molecular mimicry), and changes in immune regulation over time. The immune attack can cause inflammation that is sometimes painful or functionally disabling, though in other cases it produces mild or few symptoms (asymptomatic or subclinical) until significant damage accumulates.

Types and examples

Autoimmune conditions range from organ‑specific disorders to systemic diseases that affect multiple tissues. Common examples include:

  • Type 1 diabetes (pancreatic islet destruction)
  • Rheumatoid arthritis (joint inflammation and erosion)
  • Systemic lupus erythematosus (multi‑organ autoimmunity)
  • Multiple sclerosis (immune attack on central nervous system myelin)
  • Hashimoto thyroiditis and Graves disease (thyroid autoimmunity)
  • Celiac disease (immune reaction to gluten affecting the gut)

Diseases caused by these processes are collectively described as autoimmune diseases, a heterogeneous group with variable courses and outcomes.

Diagnosis and treatment

Diagnosis relies on clinical patterns, laboratory tests for autoantibodies, imaging, and sometimes tissue biopsy. Management aims to reduce immune‑mediated damage and control symptoms. Approaches include general immunosuppressive drugs, corticosteroids, disease‑modifying antirheumatic drugs, and targeted biological therapies that interfere with specific immune pathways. Nonpharmacologic measures—physical therapy, diet adjustments, and symptom management—are also important. Treatment often balances reducing harmful immune activity with preserving protection against infections.

History, research and notable facts

Recognition of self‑directed immune injury developed over the 20th century as serologic and cellular evidence accumulated. Experimental models have shown that autoimmunity can be provoked in the laboratory by exposing the immune system to self‑components under permissive conditions, which has helped researchers explore mechanisms. Current research areas include genetic risk profiling, the role of the microbiome, precision immunotherapies, and strategies to restore immune tolerance without broad suppression.

Distinctions and impact

Autoimmune conditions vary in onset, severity and prognosis. They are more frequent in women for many diseases and can present at any age. Some follow a relapsing‑remitting course while others progress slowly. Early recognition and tailored therapy improve long‑term function and quality of life. For general patient information and clinical resources, see links to foundational topics: medical overview, immune system basics, viral triggers, bacterial exposures, pathogen interactions, inflammatory responses, pain management, asymptomatic cases, and broader information on autoimmune diseases.